Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schussler

Showing results (321-330 of 361) with videos related to

Pageof 37
Sort By:
Vaccine|July 28, 2020
Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccinesSabrina H Tsang, Partha Basu, Noemi Bender, et al.
The Journal of Infectious Diseases|September 5, 2020
Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA StudyJoseph E Tota, Frank Struyf, Allan Hildesheim, et al.
Plant Biotechnology Journal|October 6, 2021
A vegetative storage protein improves drought tolerance in maizeHari K R Abbaraju, Rajeev Gupta, Laura M Appenzeller, et al.
Virology|May 26, 2005
The carcinogenicity of human papillomavirus types reflects viral evolutionMark Schiffman, Rolando Herrero, Rob Desalle, et al.
Salud Publica De Mexico|December 7, 2023
Loretto J Carvajal, Rolando Herrero, María M Angulo, et al.
The Lancet. Infectious Diseases|July 19, 2025
Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9-14 years compared with three doses of quadrivalent HPV vaccine in women aged 18-25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trialBernal Cortés, Rebeca Ocampo, Carolina Porras, et al.
Vaccine|January 26, 2018
Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studiesAimée R Kreimer, Rolando Herrero, Joshua N Sampson, et al.
NPJ Vaccines|March 30, 2022
HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trialSabrina H Tsang, John T Schiller, Carolina Porras, et al.
JACC. Advances|January 6, 2025
Estimating the Risk of Cardiovascular Events in U.S. Veterans Using the SMART Risk ScoreSubhash Banerjee, Rick A Weideman, David A Jacob, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|March 20, 2004
Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,M Concepción Bratti, Ana C Rodríguez, Mark Schiffman, et al.
Pageof 37

Showing results (321-330 of 361) with videos related to

Sort By:
Pageof 37
Vaccine|July 28, 2020
Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccinesSabrina H Tsang, Partha Basu, Noemi Bender, et al.
The Journal of Infectious Diseases|September 5, 2020
Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA StudyJoseph E Tota, Frank Struyf, Allan Hildesheim, et al.
Plant Biotechnology Journal|October 6, 2021
A vegetative storage protein improves drought tolerance in maizeHari K R Abbaraju, Rajeev Gupta, Laura M Appenzeller, et al.
Virology|May 26, 2005
The carcinogenicity of human papillomavirus types reflects viral evolutionMark Schiffman, Rolando Herrero, Rob Desalle, et al.
Salud Publica De Mexico|December 7, 2023
Loretto J Carvajal, Rolando Herrero, María M Angulo, et al.
The Lancet. Infectious Diseases|July 19, 2025
Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9-14 years compared with three doses of quadrivalent HPV vaccine in women aged 18-25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trialBernal Cortés, Rebeca Ocampo, Carolina Porras, et al.
Vaccine|January 26, 2018
Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studiesAimée R Kreimer, Rolando Herrero, Joshua N Sampson, et al.
NPJ Vaccines|March 30, 2022
HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trialSabrina H Tsang, John T Schiller, Carolina Porras, et al.
JACC. Advances|January 6, 2025
Estimating the Risk of Cardiovascular Events in U.S. Veterans Using the SMART Risk ScoreSubhash Banerjee, Rick A Weideman, David A Jacob, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|March 20, 2004
Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,M Concepción Bratti, Ana C Rodríguez, Mark Schiffman, et al.
Pageof 37